AEON Biopharma, Inc.
AEON- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001837607
In the last 90 days, AEON Biopharma, Inc. insiders filed 1 open-market purchase and 0 sales; 22 institutions reported holding it in 13F filings for Q2 2026, worth $9.22M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in AEON Biopharma, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- +3 vs. Q2 2025
- Shares held
- 1.36M
- +93.2K (+7.3%) vs. Q2 2025
- Total value
- $1.10M
- +$517.6K (+88.4%) vs. Q2 2025
- New holders
- 5
- 2 more added
- Sold out
- 2
- 3 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AEON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 22 | $9.22M |
| Q1 2026 | 24 | $2.80M |
| Q4 2025 | 22 | $1.67M |
| Q3 2025 | 21 | $1.10M |
| Q2 2025 | 18 | $585.7K |
| Q1 2025 | 16 | $884.8K |
| Q4 2024 | 37 | $4.80M |
| Q3 2024 | 30 | $10.1M |
| Q2 2024 | 25 | $8.73M |
| Q1 2024 | 27 | $103.5M |
| Q4 2023 | 20 | $56.8M |
| Q3 2023 | 16 | $29.3M |
| Q2 2023 | 17 | $12.0M |
| Q1 2023 | 21 | $19.6M |
| Q4 2022 | 86 | $248.3M |
| Q3 2022 | 81 | $226.5M |
| Q2 2022 | 73 | $213.1M |
| Q1 2022 | 71 | $202.3M |
| Q4 2021 | 73 | $192.0M |
| Q3 2021 | 59 | $171.8M |
| Q2 2021 | 47 | $126.0M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding AEON Biopharma, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Danske Bank A/S | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 21 | $17 | 0.00% | +21 | New |
| CIBC Private Wealth Group, LLC | 33 | $27 | 0.00% | 00.0% | Unchanged |
| MAI Capital Management | 58 | $47 | 0.00% | 00.0% | Unchanged |
| Wolff Wiese Magana LLC | 67 | $55 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 90 | $73 | 0.00% | 00.0% | Unchanged |
| GHP Investment Advisors, Inc. | 95 | $77 | 0.00% | +71+295.8% | Added |
| Steward Partners Investment Advisory, LLC | 100 | $81 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 106 | $86 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 150 | $121 | 0.00% | 00.0% | Unchanged |
| DuPont Capital Management Corp | 170 | $137 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,192 | $964 | 0.00% | −30,408−96.2% | Reduced |
| Bank of America Corp | 2,376 | $1.92K | 0.00% | −9−0.4% | Reduced |
| BlackRock, Inc. | 2,834 | $2.29K | 0.00% | −21−0.7% | Reduced |
| Jane Street Group, LLC | 10,420 | $8.43K | 0.00% | +10,420 | New |
| XTX Topco Ltd | 16,162 | $13.1K | 0.00% | +16,162 | New |
| StoneX Group Inc. | 17,578 | $14.2K | 0.00% | +17,578 | New |
| Blue Owl Capital Holdings LP | 42,353 | $34.2K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 47,073 | $38.1K | 0.00% | +26,378+127.5% | Added |
| Vanguard Group Inc | 98,568 | $79.7K | 0.00% | +98,568 | New |
| Dauntless Investment Group, LLC | 1,125,000 | $909.7K | 2.39% | 00.0% | Unchanged |
| HRT Financial LP | 0 | $0 | 0.00% | −45,258−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −272−100.0% | Sold out |